지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
Background: Osteopenia patients have a risk of fracture and may develop osteoporosis. We investigated physicians’ management of osteopenia patients in South Korea. Methods: A survey was conducted using a questionnaire including 6 items: (1) do you think anti-osteoporosis medications are necessary in osteopenia patients?; (2) what is your preference to manage osteopenia patients, except for anti-osteoporosis medications?; (3) what is your indication for the anti-osteoporosis medication in osteopenia patients?; (4) what kind of anti-osteoporosis medication do you prefer to treat osteopenia patients?; (5) do you use bisphosphonates?; and (6) if not, what is the reason for not using?. Results: Among the 173 participants, 150 (86.7%) replied that anti-osteoporosis medications were necessary in osteopenia patients. Indications for the medication were (1) past medical history of pathologic fracture in 85 (49.1%); (2) T-score <-2.5 on dual energy X-ray absorptiometry in 73 (42.2%); (3) previous history of osteoporosis in 44 (25.4%); (4) risk of fracture according to fracture risk assessment tool in 34 (19.7%); and (5) progressive bone loss in 31 (17.9%). One hundred and sixteen (67.1%) favored bisphosphonates, 93 (53.8%) selective estrogen-receptor modulator, and 24 (13.9%) hormone replacement therapy. Thirty-one (17.9%) replied that they do not use bisphosphonates due to (1) restricted reimbursement by the health insurance in 24 (77.4%); and (2) bisphosphonate-related complications in 19 (61.3%). Conclusions: Most respondents (86.7%) thought anti-osteoporosis medications were necessary in osteopenia patients, but 17.9% of the respondents did not use bisphosphonates. Restricted reimbursement by the national health insurance was the major obstacle against the use of bisphosphonates.
목차
등록된 정보가 없습니다.
참고문헌 (22)
참고문헌 신청
Zhang J / 2013 / Osteopenia : debates and dilemmas / Curr Rheumatol Rep 15:384
Black DM / 1992 / Axial and appendicular bone density predict fractures in older women / J Bone Miner Res 7:633~638
Gourlay ML / 2012 / Bone-density testing interval and transition to osteoporosis in older women / N Engl J Med 366:225~233
Hillier TA / 2011 / WHO absolute fracture risk models(FRAX) : do clinical risk factors improve fracture prediction in older women without osteoporosis / J Bone Miner Res 26:1774~1782
Cranney A / 2007 / Low bone mineral density and fracture burden in postmenopausal women / CMAJ 177:575~580
Black DM / 1992 / Axial and appendicular bone density predict fractures in older women / J Bone Miner Res 7:633~638
Gourlay ML / 2012 / Bone-density testing interval and transition to osteoporosis in older women / N Engl J Med 366:225~233
Hillier TA / 2011 / WHO absolute fracture risk models(FRAX) : do clinical risk factors improve fracture prediction in older women without osteoporosis / J Bone Miner Res 26:1774~1782
Cranney A / 2007 / Low bone mineral density and fracture burden in postmenopausal women / CMAJ 177:575~580
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
The Effects of Low-Dose Bisphosphonate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Patients With Osteoporosis
Annals of geriatric medicine and research
2016 .01
-
Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis
Gut and Liver
2021 .09
-
Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?
대한골대사학회지
2016 .01
-
The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany
Cancer Research and Treatment
2015 .01
-
Effect of bisphosphonate on temporomandibular joint in osteopenia-induced rats by botulinum toxin A injection on masticatory muscle: a preliminary study
Maxillofacial Plastic Reconstructive Surgery
2019 .01
-
Which Bisphosphonate? It’s the Compliance!: Decision Analysis
대한골대사학회지
2016 .01
-
Oral Bisphosphonate and Risk of Esophageal Cancer: A Nationwide Claim Study
대한골대사학회지
2015 .01
-
Bisphosphonate-Related Osteonecrosis in a Patient with Florid Cemento-Osseous Dysplasia
Journal of Oral Medicine and Pain
2021 .06
-
Review on the comparison of effectiveness between denosumab and bisphosphonates in post-menopausal osteoporosis
Osteoporosis and Sarcopenia
2016 .01
-
Position Statement: Drug Holiday in Osteoporosis Treatment with Bisphosphonates in South Korea
대한골대사학회지
2015 .01
-
The Association between Treatment with Bisphosphonates and the Risk of Atrial Fibrillation: A Meta-Analysis of Observational Studies
Korean Journal of Family Medicine
2022 .01
-
Bisphosphonate-related osteonecrosis of the jaw in patients received long term treatment of oral bisphosphonate administration: Case reports
Oral Biology Research
2016 .01
-
Clinical features of atypical femur fracture
Osteoporosis and Sarcopenia
2016 .01
-
The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis
대한골대사학회지
2017 .01
-
Bisphosphonate-related osteonecrosis of the jaw in a patient with osteoporosis following treatment of testicular cancer: a case report
대한구강악안면외과학회지
2015 .01
-
Altered VEGF Regulation in Ovariectomized Rat Alveolar Bone Sockets by Bisphosphonate
대한구강해부학회지
2018 .01
-
Bisphosphonate-related osteonecrosis of the jaw in a multiple myeloma patient: A case report with characteristic radiographic features
Imaging science in dentistry
2015 .01
-
A case of bisphosphonate-related osteonecrosis of the jaw with a particularly unfavourable course: a case report
대한구강악안면외과학회지
2017 .08
-
Comment to “Radiographic changes of mandibular cortical bone in bisphosphonate drug holiday”
대한구강악안면외과학회지
2023 .02
-
The Trend in the Sales of Menopausal Hormone and Other Osteoporosis Medications in South Korea from 2016 to 2019
대한골대사학회지
2021 .08
이 논문의 저자 정보
최근 본 자료
댓글(0)
0